β-blockers modify the prognostic value of adiponectin in chronic heart failure

scientific article published on 20 May 2010

β-blockers modify the prognostic value of adiponectin in chronic heart failure is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IJCARD.2010.04.039
P698PubMed publication ID20488568

P50authorPaul J BeckersQ51718307
Monique ElseviersQ55232822
Samuel CoenenQ30505135
Viviane M. ConraadsQ43183498
P2093author name stringChristiaan J Vrints
Vicky Y Hoymans
Nadine Possemiers
An M Van Berendoncks
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectheart failureQ181754
chronic heart failureQ11829287
P304page(s)296-300
P577publication date2010-05-20
P1433published inInternational Journal of CardiologyQ2357863
P1476titleβ-blockers modify the prognostic value of adiponectin in chronic heart failure
P478volume150

Reverse relations

cites work (P2860)
Q37316110Adiponectin deficiency blunts hypoxia-induced mobilization and homing of circulating angiogenic cells.
Q38054603Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure
Q45362673Association Between Epicardial Fat Thickness and Weight Homeostasis Hormones in Patients With Noncachectic Heart Failure
Q91959031Association between elevated adiponectin level and adverse outcomes in patients with heart failure: a systematic review and meta-analysis
Q87661825Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failure
Q37719007Circulating Adiponectin Levels Following Treatment Can Predict Late Clinical Outcomes in Chronic Heart Failure.
Q36974044Circulating Omentin-1 Levels Are Decreased in Dilated Cardiomyopathy Patients with Overt Heart Failure
Q37855653Functional adiponectin resistance and exercise intolerance in heart failure.
Q35648249Plasma adiponectin concentration and its association with metabolic syndrome in patients with heart failure
Q48275039The Role of Serum Adiponectin for Outcome Prediction in Patients with Dilated Cardiomyopathy and Advanced Heart Failure
Q84981504The appropriate number of endpoints to keep validity for Cox proportional hazard analysis
Q38915167The evolving role of adiponectin as an additive biomarker in HFrEF.
Q38017586Unraveling new mechanisms of exercise intolerance in chronic heart failure. Role of exercise training

Search more.